SCM
DRUG

Sio Capital Management’s Bright Minds Biosciences DRUG Stock Holding History

Sio Capital Management’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.28M Buy
86,083
+4,200
+5% +$338K 0.9% 37
2025
Q4 		$6.39M Sell
81,883
-108,881
-57% -$7.28M 1.01% 27
2025
Q3 		$11.6M Sell
190,764
-321,574
-63% -$12.5M 2.93% 13
2025
Q2 		$13.4M Buy
512,338
+4,776
+0.9% +$143K 5.11% 6
2025
Q1 		$18.3M Buy
507,562
+55,769
+12% +$2.04M 5.45% 7
2024
Q4 		$16.3M Buy
+451,793
New +$15.9M 4.58% 7

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Sio Capital Management's DRUG Position: Q1 2026 in Review

Sio Capital Management increased its Bright Minds Biosciences (DRUG) stake by 5.1% in Q1 2026, buying an estimated $338K and bringing the position to 86,083 shares worth $6.28M. The position accounts for 0.9% of the portfolio, ranked #37.

Sio Capital Management first reported a position in DRUG in Q4 2024 and has held it in 6 quarters since. The position peaked at $18.3M in Q1 2025. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Sio Capital Management held 86,083 shares of Bright Minds Biosciences worth $6.28M as of Q1 2026.
  • Sio Capital Management bought 4,200 Bright Minds Biosciences shares in Q1 2026, an estimated $338K.
  • Bright Minds Biosciences made up 0.9% of Sio Capital Management's portfolio in Q1 2026, its #37 holding.
  • Sio Capital Management first reported a position in Bright Minds Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Sio Capital Management's Bright Minds Biosciences position peaked at $18.3M in Q1 2025.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Sio Capital Management's 13F filing for Q1 2026, filed 14 May 2026.